Answers are grounded in this paper and cite their sources.
A specific cysteine residue in NAD-dependent glutamate dehydrogenase from Neurospora crassa was labeled with N-ethyl[1-14C]maleimide. Inactivation of the modified enzyme with pyridoxal 5'-phosphate followed by reduction with NaBH4 resulted in the preferential labeling of 4 to 4.5 lysine residues per subunit. Tryptic hydrolysis of the doubly labeled enzyme yielded a single radioactive peptide containing a S-(N-ethyl[14C]succinimido)cysteine residue, and its sequence was identified as Val-Leu-Cys*-Asp-Asp-Thr-Asn-Val-Thr-Leu-Pro-Asp-Gly-(Val,Gln,Asn)-His-Gly-Thr-Ala-Phe-Arg. Five fluorescent peptides containing e-N-(5'-phosphopyridoxyl)lysine residues were isolated from the digest, and their sequences were determined as: (a) Ser-Lys*-Glu-Ala-Tyr-Gln-Ile-Asn-Ala-Arg; (b) Ala-Thr-Lys*-Asn-Thr-Lys; (c) Leu-Glu-Lys*-Lys; (d) Leu-Ala-Lys*-Ala-Arg; (e) Lys*-Asn-Lys. None of the sequences of the labeled peptides showed homology with regions containing essential lysine residues or the cysteine residues in other glutamate dehydrogenases previously described; however, there may have been additional labeled peptides representing different sequences that were not obtained.
No takes yet. Share an insight, caveat, or question.
Veronese et al. (1974) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: